Drugs / AM3101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05560477 | Apr 2023 → Jan 2027 expected | — | University of Cincinnati | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AM3101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05560477 ↗ |